New Self-Test could slash cervical cancer rates in developing nations
NCT ID NCT07232355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Honduras tests a new way to prevent cervical cancer using a self-collected HPV test that gives results in under an hour, combined with AI-powered imaging. 5,000 women will participate to see if this same-day screening-and-treatment approach is accurate, feasible, and cost-effective. The goal is to make screening easier and reduce the number of women who miss follow-up care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AmpFire® HPV test (self-sampling kit) and Automated Visual Evaluation (AI imaging)
- What this could lead to
- If successful, this approach could make cervical cancer screening faster, cheaper, and more accessible in low-resource countries, potentially preventing many cases.
- What could go wrong
- This is a large feasibility study, not a final proof of cure. The test and AI triage may not perform as expected in real-world settings, and cost-effectiveness remains to be proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 OR WORSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atila Biosystems, Inc.
RECRUITINGSunnyvale, California, 94085, United States
-
Basic Health International
RECRUITINGSan Salvador, El Salvador
-
Centro de Salud Las Crucitas
RECRUITINGTegucigalpa, Honduras
-
Ciudad Mujer Kennedy
RECRUITINGTegucigalpa, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the HPV vaccine fully protect transgender women and people with HIV?
- Tweets that tell a story: a new approach to boosting HPV vaccination
- Could HPV shots start earlier? study tests vaccine in kids as young as 4
- Immune cell therapy takes on HPV
- ERs may soon offer At-Home HPV tests to reach women who skip screenings
- Double probe heat therapy may slash cervical cancer risk in HIV-positive women